Discover our products

TheraPanacea exploits the latest scientific advances in the fields of machine learning, artificial intelligence & high-performance computing and simulation towards digital, personalized, adaptive medicine that creates advanced software solutions for assisting and guiding cancer treatment in the context of radiation therapy.

The “Thera-” software technology/suite of radiation therapy (e.g. treatment planning system (TPS)) is the first effective solution for direct dose estimation at planning, dose cumulative estimation and explicit dose adjustment at treatment. Our solution involves a full-scale treatment planning system that comprises of the following components:


Data-driven solution for automatic, tumor and multiple-organ annotation that combines massive deep learning and computational anatomy.


Treatment planning solution that introduces fast, efficient, and exact Monte-Carlo simulation directly in the dose optimization.


Real-time solution that proposes an adaptive positioning accounting for the evolution of anatomy and provides an exact estimate on the dose delivered.


The “quasi” real-time solution for on the fly treatment planning that eliminates positioning errors and adjusts radiation to the patient’s anatomy.

The people behind Therapanacea

Catherine holds a M.Eng. in nuclear engineering (INPG, 2000) and has more than 15 years of experience in management acquired in Europe, North America and China on digital transformation & consulting. She is native in French and fluent English & Chinese.

Catherine Martineau-Huynh, M.Eng.
Chief Operating Officer

Rafael holds a M.Eng. in applied mathematics (Ecole Polytechnique, 2009) and a M.Sc. in machine learning, and computer vision (Ecole Normale Supérieure de Cachan, 2010). He is native in Portuguese and fluent in English & French.

Rafael Marini Silva, M.Eng.M.Sc.
Chief Architect

Nikos holds PhD in electrical and computer engineering (Inria, 2000). He has more than 20 years of experience on cutting edge research in the areas of computer vision, medical imaging and machine learning and optimization and has published more than 250 papers, holds 25 international patents. and has supervised more than 30 PhD thesis. He is native in Greek and fluent English & French.

Professor Nikos Paragios PhD
Chief Executive & Technical Officer

Out team consists of a highly qualified/international team composed by  members of the technical staff with PhD/MSc in scientific computing/artificial intelligence, engineers with expertise in machine learning, biomedical image analysis and medical physics, software developers with expertise in web applications, egonomists and regulatory experts.


Use your talents and skills to serve an high impact societal project against cancer! Join us and be part of an exciting and useful adventure in an international environment in the center of Paris.

We are currently hiring : marketing and communication officer, front-end developer, business development managers and more…

Want to work with us ?


Boards & Advisors


Dr. N. Ayache
Research Director at INRIA


Pr. E. Deutsh
Doctor, Research at Gustave Roussy, molecular radiotherapy study group leader


Pr. B. Gallix
Professor, Chair, Diagnostic Radiology at McGill University


Pr. E. Lartigau
Research center Oscar Lambret Director


Dr. William Wells
Professor of Radiology, Harvard Medical School

About Therapanacea

Our Partners & Business Investors .

Get in touch

Any ideas, questions or comments to our project? Please feel free to share or ask and get in touch with us through the form.